MID-VOLUME · HOSP-HEAVY
cefuroxime Side Effects
cefuroxime (also sold as Ceftin, Zinacef) sits MID-VOLUME #307 of 524 by FAERS report count. Lead signal: HOSP-HEAVY - 47.2% mention hospitalization (5,229 reports). Demographics and serious-outcome tables follow.
Data updated 2026-05-15
- 11,087
- FAERS reports
FDA Adverse Event Reporting System extract for cefuroxime. Stamp set WATCHLIST · DEATH-HEAVY · HOSP-HEAVY. How figures are compiled.
cefuroxime: 47.2% mention hospitalization (5,229 reports). Death stamp DEATH-HEAVY; volume band MID-VOLUME #307 of 524 by FAERS report count.
Mid-book FAERS page for cefuroxime (Ceftin) (11,087 reports). Signature HOSP-HEAVY. Dominant age band on file: 45-64. Educational reference only.
Counts from the openFDA FAERS extract (2004–2025). Stamps WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
DYSPNOEA leads 738 of 11,087 reports
Who reports · age peak 45-64 (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 45-64 (2,559 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (1,324 reports, 11.9%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| DEATH | 307 |
| RENAL FAILURE | 162 |
| DYSPNOEA | 156 |
| PNEUMONIA | 147 |
| PYREXIA | 142 |
| SEPSIS | 120 |
| CONDITION AGGRAVATED | 109 |
| ACUTE KIDNEY INJURY | 105 |
| ANXIETY | 105 |
| DIARRHOEA | 91 |
| RESPIRATORY FAILURE | 84 |
| CHRONIC KIDNEY DISEASE | 83 |
| PRODUCTIVE COUGH | 79 |
| RENAL IMPAIRMENT | 76 |
| HAEMOPTYSIS | 75 |
| MULTI-ORGAN FAILURE | 75 |
| SEPTIC SHOCK | 74 |
| HYPOXIA | 73 |
| CARDIAC ARREST | 72 |
Reactions in Hospitalization Reports
Hospitalization is HEAVY (5,229, 47.2% of the book). Top reactions in those rows:
| Reaction | Reports |
|---|---|
| DYSPNOEA | 475 |
| PNEUMONIA | 455 |
| PYREXIA | 446 |
| DIARRHOEA | 377 |
| ACUTE KIDNEY INJURY | 282 |
| CONDITION AGGRAVATED | 273 |
| NAUSEA | 260 |
| VOMITING | 253 |
| RENAL FAILURE | 245 |
| SEPSIS | 234 |
| DRUG INTERACTION | 227 |
| ANXIETY | 223 |
| FATIGUE | 218 |
| URINARY TRACT INFECTION | 210 |
| PAIN | 206 |
| PULMONARY EMBOLISM | 204 |
| ASTHENIA | 196 |
| MALAISE | 187 |
How to read cefuroxime FAERS figures (WATCHLIST · DEATH-HEAVY · HOSP-HEAVY)
FAERS holds 11,087 voluntary reports linked to cefuroxime (Ceftin, Zinacef), 2004-2025. Death is listed on 1,324 (11.9%). Hospitalization appears on 5,229 (47.2%). Top co-reported indication: Product Used For Unknown Indication.
Mid-volume extract - treat DEATH-HEAVY · HOSP-HEAVY as signal-detection rates next to 47.2% mention hospitalization (5,229 reports).
Read with cefuroxime
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-HEAVY stamps.
ABS(total_reports) peer at 11,035 FAERS cases (Δ 52 lighter vs cefuroxime); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 11,019 FAERS cases (Δ 68 lighter vs cefuroxime); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 11,247 FAERS cases (Δ 160 heavier vs cefuroxime); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 11,257 FAERS cases (Δ 170 heavier vs cefuroxime); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 50.2 pp vs cefuroxime's DEATH-HEAVY): CASELOAD · HOSP-MID.
cefuroxime stamps DEATH-HEAVY · HOSP-HEAVY; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload WATCHLIST and the label guide.